cigna glp-1 coverage drops of obesity drugs for its own employees Weight Loss Management
Description
GLP-1 vs.
What is a GLP-1 Receptor Agonist

Looking ahead, the influence of US policy and Most Favoured Nation (international reference) pricing will remain a central trend that shaped obesity care in 2025 and will continue to do so into 2026 and beyond

Dealing with PCOS

Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic poly-peptide (GIP, previously known as gastric inhibitory polypeptide) are key incretin